Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Legend Biotech Corporation

Legend Biotech Corporation (LEGN)

Market is closed
News
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call Transcript

Legend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode.

Keep Reading →

November 13th, 2024 - News Transcripts

10 Most Promising Biotech Stocks According to Hedge Funds

10 Most Promising Biotech Stocks According to Hedge Funds

Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.

Keep Reading →

October 11th, 2024 - Hedge Funds Industries News

Here's Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio

Here's Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” second-quarter 2024 investor letter.

Keep Reading →

September 12th, 2024 - Hedge Fund Investor Letters News

10 Largest Biotech Hedge Funds and Their Top Stock Picks

10 Largest Biotech Hedge Funds and Their Top Stock Picks

The ability to successfully make money through investment requires deep thinking and analysis.

Keep Reading →

September 11th, 2024 - Hedge Funds News

Ray Dalio’s Top 10 Growth Stock Picks with 30+% Revenue Growth

Ray Dalio’s Top 10 Growth Stock Picks with 30+% Revenue Growth

Valuing a stock comes in several shapes and flavors. The most common of these is the price to earnings ratio.

Keep Reading →

July 29th, 2024 - Hedge Funds News

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter. A copy of the letter can be downloaded here.

Keep Reading →

June 24th, 2024 - Hedge Fund Investor Letters News

Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript

Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech First Quarter 2024 Financial Results Conference Call.

Keep Reading →

May 15th, 2024 - News Transcripts

11 Oversold MidCap Stocks To Buy Now

11 Oversold MidCap Stocks To Buy Now

In this piece, we will take a look at the 11 oversold midcap stocks to buy now.

Keep Reading →

April 25th, 2024 - Hedge Funds News

Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

April 3rd, 2024 - Hedge Fund Investor Letters News

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.

Keep Reading →

March 29th, 2024 - Hedge Fund Investor Letters News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)